PSA is an oncodevelopmental antigen usually expressed in human tumors with high metastatic potential. Here we set up a metastatic model in nude mice by using TE671 cells, which strongly express PSA-NCAM. We observed the formation of lung metastases when TE671 cells were injected intravenously, intramuscularly, and intraperitoneously, but not subcutaneously. Intraperitoneous injections also induced peritoneal carcinosis, ascites, and liver metastases. To evaluate the putative role of PSA in the metastatic process we used a speci®c cleavage of PSA on NCAM by endoneuraminidase-N on intraperitoneous primary tumors. Mice with primary intramuscular tumors were taken as control. Repeated injections of endoneuraminidase-N led to a decrease in PSA expression in primary intraperitoneous nodules and ascites but not in intramuscular primary tumors. Endoneuraminidase-N also increased the delay in ascitic formation and decreased the number of lung or liver metastases in the case of intraperitoneous tumors but not in the case of intramuscular tumors. When metastases occurred in endoneuraminidase-N injected animals, they strongly expressed PSA-NCAM. Therefore, we established a relationship between PSA expression on the surface of primary tumor cells and the metastatic process. Oncogene (2001) 20, 997 ± 1004.
Introduction
Adhesiveness and migration are central aspects of the metastatic process. Thus modulation of adhesion molecules of the tumor cells could be a key factor for controlling the metastatic cascade. Several studies have shown a relationship between loss of cadherin or integrin molecules and acquisition of an invasive phenotype by tumor cells (Navarro et al., 1991) . Carbohydrate structures like mucin-associated sialoglycoproteins have been used to determine prognosis in patients with colorectal cancer; increased sialylation of mucin carbohydrates is associated with a higher metastatic potential (Bresalier et al., 1996) .
The Neural Cell Adhesion Molecule (NCAM), a member of the immunoglobulin (Ig) superfamily, has been widely studied since it intervenes in many cell ± cell and/or cell ± substrate interactions via homophilic and heterophilic mechanisms. Alternative splicing of one gene yields several isoforms, which dier according to their protein backbone, mode of attachment to the plasma membrane, and content of a2 ± 8 linked sialic acid residues (polysialic acids or PSA) (Rutishauser et al., 1988) .
PSA residues constitute up to 30% of the molecular mass of the highly sialylated NCAM isoforms (PSA-NCAM) and are attached to the 5th Ig domain (Finne et al., 1983; Rougon et al., , 1993 Cremer et al., 1994) . Because of its negative charges and large hydrated volume, PSA on NCAM attenuate adhesion (Sadoul et al., 1983) . Thus its presence on cell surfaces could permit cells to detach from their neighbors, thereby allowing them to migrate or to undergo changes in shape related to mobility or structural plasticity. The spatiotemporal pattern of PSA-NCAM expression correlates well with such roles during histogenesis (Rougon and Marshat, 1986; Lackie et al., 1990; Figarella-Branger et al., 1992) . There is direct evidence both for the contribution of PSA to the mobility of O-2A glial progenitor cells from neurohypophyseal explants (Wang et al., 1994) and for the migration of olfactory bulb interneuron precursors in the subventricular zone (Hu et al., 1996) .
PSA-NCAM is expressed by several human neurectodermal tumors, including medulloblastomas, subclasses of neuroblastomas, small cell lung carcinomas, and rhabdomyosarcomas (Figarella-Branger et al., 1990; Molenaar et al., 1991; Scheiddeger et al., 1994) . These tumors are known for their aggressive behavior and their ability to form metastases. It is likely that PSA-NCAM expression is related to the metastatic growth potential of tumor cells. We showed previously that PSA-NCAM levels in the cerebrospinal¯uid (CSF) correlate with CSF metastases of medulloblastomas (Figarella-Branger et al., 1996) . Similarly, PSA-NCAM expression is high in serum of patients with advanced stages of rhabdomyosarcomas and neuroblastomas (GluÈ er et al., 1998a,b) .
The present study was undertaken to elucidate whether PSA-NCAM is involved in the formation of metastases. For this purpose, we describe a metastatic model in nude mice set up by using the human cell line TE 671 (MacAllister et al., 1977) , characterized as a rhabdomyosarcoma cell line (Stratton et al., 1989) . Both intramuscular (i.m.) and intraperitoneous (i.p.) injections of cells gave rise to lung metastases. We show that enzymatic removal of PSA on i.p. primary tumors decreased the formation of metastases when compared to untreated animals or animals exhibiting i.m. primary tumors that cannot be reached by the i.p. injected enzyme.
Results

Development of a spontaneous metastatic model of human rhabdomyosarcoma lung metastases
One million (10 6 ) viable cells were inoculated in irradiated mice as described in Materials and methods.
All subcutaneously (s.c.), i.m., and i.p. inoculated animals developed tumors. Tumor growth was dependent on the injection site; the tumors could be detected 2 and 3 weeks after i.m. and s.c. injection respectively. Ascites were clinically observed 6 weeks after the i.p. injection. When mice were killed, the mean volume of s.c. inoculated tumors was 1310+537 mm 3 . The mean increase in thigh circumference of the i.m. inoculated tumors was 31+10.3 mm. All i.p. inoculated animals developed peritoneal carcinosis; mean increase in abdominal circumference was 59.2+9.3 mm.
Occurrence of spontaneous metastases depended on the route of injection. None of the s.c. injected mice showed metastases. Lung metastases were observed in ®ve of seven, ®ve of six, and three of six mice with i.p., intravenous (i.v.), and i.m. injections respectively. Lung metastases were microscopic and composed of up to 20 cells within the alveoli walls ( Figure 1a ) and the pulmonary vessels (Figure 1b) . No brain or spleen metastases were observed. In addition, 5 of 6 i.p. injected mice showed a diuse peritoneal carcinosis and in¯ammatory ascites. Liver metastases were observed in 5 of 6 i.p. injected mice, but in none of the other animals. These metastases were located within the liver and not at the organ surface.
Immunoperoxidase studies performed on s.c., i.m., and i.p. tumors showed strong PSA-NCAM immunostaining on the surface of all tumor cells (Figure 2b ). Strong immunostaining was also observed on the cell surface of all metastases (Figure 2d ).
Monitoring of PSA-NCAM expression after PSA enzymatic removal in culture Double immuno¯uorescence labeling experiments showed that all TE 671 cells in culture expressed both NCAM (Figure 3a ) and PSA-NCAM ( Figure  3b ) on their cell surface. When endoneuraminidase-N (Endo-N) was added to the culture medium, PSA expression was completely abolished after 24 h. This lack of PSA persisted for at least 72 h without further addition of the enzyme (Figure 3d) . At 120 h after Endo-N addition, weak PSA immunostaining was detected (Figure 3f ). Overall these experiments showed that the enzyme was stable in the culture medium for at least 4 days. Note that Endo-N addition removed PSA without altering NCAM (Figure 3c,e) .
In order to monitor PSA expression after Endo-N addition, protein extracts from TE 671 cell line were analysed by Western blot using anti-PSA antibody at dierent times of Endo-N addition. Twenty-four hours and 72 h (Figure 4a , lanes 2 and 3) after addition PSA was completely abolished and not detectable by Western blot analysis compared to the TE 671 control (Figure 4a , lane 1). The reexpression of PSA after 120 h was showed by the reappearance of the band characteristic of PSA at 200 ± 250 kDa (Figure 4a, lane 4) . We performed a Western blot with anti-NCAM antibody to evaluate the NCAM expression by TE671 cells, which were or were not treated with Endo-N. In these two conditions NCAM migrated as a major band of 140 kDa ( Figure 4b ). Results were similar with¯ow cytometry, which showed that all TE 671 cells were double-labeled by anti-NCAM and anti-PSA antibodies (Figure 5a ). At 24 h ( Figure 5b ) and 72 h (Figure 5c ) after the Endo-N addition, only NCAM expression was detected. At 120 h, most cells again expressed PSA-NCAM and NCAM ( Figure 5d ). PSA enzymatic removal did not aect proliferation and viability of TE 671 cells in culture ( Figure 6 ). Overall, these data show that one single addition of Endo-N in the culture medium of the TE 671 cells remove speci®cally PSA without aecting NCAM expression nor the proliferation and the viability of the cells in vitro.
Enzymatic removal of PSA decreases lung metastases in the experimental model
The in vitro results led us to use the Endo-N to manipulate PSA expression in the mouse model described earlier. For this purpose, we veri®ed that Endo-N was not toxic in vivo. High doses of Endo-N were not toxic and no histological changes were observed after i.p. administration of 350 Endo-N units. Our rational was then to focus on i.p. and i.m. injected mice with the hypothesis that i.p. injected Endo-N would remove PSA on i.p. but not on i.m. injected cells because it could not diuse through the peritoneal barrier. Intraperitoneal Endo-N injections reduced liver and lung metastases in i.p. inoculated mice (P=0.03) (Figure 7 ). Lung metastases were observed in three of nine animals injected with Endo-N and in ®ve of six control animals. Similar results were observed for liver metastases. In addition, only four of nine Endo-N injected mice developed mild peritoneal carcinosis compared to ®ve of six control mice. Moreover, although ascites appeared at 6 weeks in the control group, 7 weeks or more were required in the Endo-N group. Immunohistochemistry showed that i.p. Endo-N administration dramatically reduced PSA expression on the surface of intraperitoneal nodules (Figure 2a ). In few peritoneal nodules, however, some cells still strongly expressed PSA-NCAM ( Figure 2b ). These cells were at the center of the nodules. Furthermore, in ascites PSA-NCAM levels as measured by the ELISA were lower in Endo-N injected mice (24.3+14.1 mg/ml) than in control animals (102+27 mg/ml, P=0.02). Endo-N adminis- 
Discussion
Tumors bearing PSA are highly metastatic, suggesting that PSA favor the metastatic process. For example, we showed that in rat pituitary transplantable tumors, PSA-NCAM expression correlates with metastatic occurrence (Daniel et al., 2000) . To establish a relationship between PSA expression and the metastatic process, we manipulated PSA expression in a novel animal metastatic model.
Hence, we ®rst set up a nude mouse model of human rhabdomyosarcoma lung metastases by using the TE 671 cell line. This cell line is a good model for human alveolar rhabdomyosarcoma because it showed the characteristic rearrangement of the Pax-3 and FKHR genes (Barr, 1997) . We showed by immuno¯uorescence, Western blot, and cytometric analyses, that all TE 671 cells strongly expressed PSA-NCAM. Interestingly, Pax-3, a developmentally regulated transcription factor, is thought to be involved in the regulation of polysialyltransferases (PSTs) responsible for the expression of PSA (Mayanil et al., 2000) .
We observed that cancer progression was determined by the host organ as already reported for other models (Togo et al., 1995; Kubota, 1994) . For this cell line, tumors grew faster in animals receiving i.m. injection than in those receiving s.c. injection. Lung spontaneous metastases were observed in most i.m. inoculated mice but in none of the s.c. injected ones probably because the s.c. environment is not favorable. In keeping with this hypothesis, other cell lines expressing PSA-NCAM such as the SCLC line NCL-H69 does not lead to lung metastases if injected s.c. (Scheiddeger et al., 1994) . Moreover our recent work (Daniel et al., 2000) indicates that the PSA expressing SMtTW4 cells did not metastasize if grafted under the rat neck skin but did if implanted under the kidney capsule. Spontaneous lung metastases were also observed after i.p. and i.v. inoculation, which indicates that the peritoneal serosa or blood vessels favor metastasis spread. We never observed brain, kidney, or spleen metastases. Liver metastases, however, were observed only after i.p. inoculation. It is interesting to note that human rhabdomyosarcomas also frequently show lung metastases, like many soft tissue sarcomas (Ganey et al., 1993) .
We then used this model to determine whether PSA favor the metastatic process. Endo-N, which speci®-cally removes PSA polymers from the cell surface after in vitro (Wang et al., 1994) and in vivo (Ono et al., 1994) injections, was instrumental in our study. First, we showed that in vitro a single Endo-N addition was sucient to completely remove PSA on NCAM on TE 671 cell surface for up to 72 h without aecting the viability nor the proliferation rate of TE 671 cells. In addition, Endo-N administration did not prevent PSTs expression by TE 671 cells as mRNAs encoding both PST and STX were still present 72 h after Endo-N addition (data not shown). Second, because massive i.p. injections of Endo-N were not toxic, we were able to inject the animals twice a week with Endo-N i.p. without observing adverse eects. The most convincing proof that PSA were actively involved in metastatic formation was that the number of lung metastases were reduced in i.p. but not in i.m. injected animals after administration of Endo-N. For i.m. tumors, Endo-N injected mice and control mice did not dier in tumor progression and metastatic formation. Indeed, when injected i.p. the Endo-N did not reach the i.m. site as shown by PSA immunostaining on primary i.m. tumors. It is likely that because the enzyme is active under a trimeric or tetrameric form (Wang et al., 1994) , it cannot diuse through the serous peritoneal barrier (Gokal, 1992) . In contrast, i.p. administration of Endo-N as expected reduced immunostaining on the cell surface of i.p. primary tumors. PSA became undetectable at the periphery of the tumors, a highly vascularized area from which cells are likely to detach and escape into the circulation. The eciency of Endo-N was further demonstrated by the observation that PSA-NCAM levels in the ascites measured by ELISA were lower in the Endo-N group than in the control group. Therefore, our study showed that Endo-N administration prevents to some extent the formation of metastases. However, as shown by in vitro and in vivo studies Endo-N did not in¯uence tumor growth. When metastases occurred in Endo-N treated animals or in control mice, they did not dier by their phenotype (PSA expression), location, or size.
The metastatic cascade includes dissociation of cells from the primary tumor, migration, vascular invasion at the local site,¯ow in the vessels, extravasation at the relevant metastatic organs, and seeding and growth at the metastatic sites (Parish et al., 1987; Aznavoorian et al., 1993; Yokota, 2000) . Which steps of the cascade are in¯uenced by PSA? Because of the main functions of the PSA it is likely that they favor at least the ®rst step of the metastatic process: cell dissociation from the primary tumor. PSA aect cell interactions through a physical impedance (via hydrated volume and/or charge repulsion) of overall membrane contacts (Acheson et al., 1991) . PSA decrease NCAM homophilic (Sadoul et al., 1983) and heterophilic adhesion (Storms and Rutishauser, 1998) and also aect a broad spectrum of cell interactions mediated by other receptors (Rutishauser et al., 1988) . It is likely that the intraperitoneal injection of Endo-N induces a Figure 7 Dierences between the metastasis occurrence in control metastatic mice and Endo-N injected mice blockade of the dissociation of TE 671 cells from the primary tumor, leading to a decrease in the number of peritoneal implants and thus peritoneal carcinosis. This hypothesis is supported by the delay in the onset of ascites in Endo-N injected animals. Endo-N administration, however, was not sucient to abolish peritoneal carcinosis and lung metastases in some animals, probably because i.p. Endo-N administration did not allow complete diusion of the enzyme on the surface of all tumor cells. As suggested by immunohistochemical results, tumor cells deep within a nodule were not accessible to the enzyme. Moreover, repeated i.p. injections could favor peritoneal ®brosis, which may decrease Endo-N diusion.
PSA may also in¯uence the metastatic process by promoting cell migration. Increased migration favor a spread from the initial tumor and also from the metastatic sites. Direct evidence that PSA favor in migration has been reported for O2-A cells (Wang et al., 1994; Ousmenar et al., 1995) and for neuronal precursors in a process called chain migration (Hu et al., 1996; Ono et al., 1994; Wichterle et al., 1997) . Whether PSA is necessary for the migration of TE 671 cells after their detachment from the primary tumor remains to be determined.
PSA could also prevent the destruction of the metastatic cells through the blood¯ow likely because of the physical impedance of the PSA. This hypothesis has been formulated for NK cells, which also express PSA-NCAM (Husman et al., 1989) . Moreover, it is possible that the same mechanisms decreased the interactions between PSA-expressing tumor cells and receptors involved in T or NK cells mediated cytotoxicity. At last, because cells bearing PSA are plastic (Rougon, 1993) , the PSA at the cell surface of the metastatic cells certainly favor the survival of these cells in a new environment. In support, the immunohistochemical study showed that all metastatic cells in Endo-N and control animals strongly expressed PSA.
In conclusion, this study showed that: (1) this new model is of particular interest to study the metastatic cascade in human rhabdomyosarcomas carrying the t(2;13)(q37-q14) translocation and to evaluate anticancer drugs in these tumors; (2) PSA favor the metastatic process at least in this model.
Materials and methods
Reagents
Anti-NCAM antibodies were prepared in our laboratory. Anti-PSA (Men-B) is a mouse IgM mAb that speci®cally recognizes a2 ± 8 linked PSA . The rabbit site directed anti-NCAM polyclonal antibody recognizes NH 2 terminal domains of all NCAM isoforms . The dilutions used for these antibodies were 1/ 100 of an ascitic¯uid and 1/1000 of a rabbit serum respectively.
Endoneuraminidase-N (Endo-N) was puri®ed from the phage K1 as previously described (Wang et al., 1994) . Brie¯y, it was titrated as 3500 U/mg with a 1 mg/ml protein concentration. A unit is de®ned as the quantity of Endo-N able to remove all PSA from 10 4 AtT20 cells when incubated for 4 h at 378C in 500 ml of DMEM. Under reducing conditions it produced a simple 90 kDa protein band on SDS ± PAGE. The same preparation was used in other in vivo studies (Theodosis et al., 1999) . Endo-N shows a strict speci®city for a2 ± 8 polymers of sialic acids (PSA) and releases oligomers of seven to nine residues. These PSA are selectively expressed by NCAM in mammals.
Cell line TE 671 cell line was obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were grown in DMEM (Gibco ± BRL, Cergy Pontoise, France), supplemented with 10% heat-inactivated fetal bovine serum (Gibco ± BRL), 2 mM L-glutamine, 10 mM pyruvate and 100 mg/ml streptomycin (Sigma Chemical, Saint-Quentin Fallavier, France), in a humidi®ed atmosphere of 5% CO 2 at 378C. Cells were passaged every 3 days using trypsin-EDTA dissociation buer (Sigma Chemical) and were grown in 75 cm 2 plastic¯asks (Falcon, Labotechnia, Carros, France) . Karyotypic analysis of this tumor cell line showed numerous structural abnormalities including t(2;13)(q37-q14). This translocation is pathognomonic of the alveolar subtype of rhabdomyosarcoma. It leads to a rearrangement of the Pax-3 and FKHR genes (Barr, 1997) .
PSA-NCAM expression after Endo-N administration
To evaluate PSA-NCAM expression in culture after one single administration of Endo-N, 10 6 TE 671 cells were cultured in four 6 cm Petri dishes (10 6 cells/dish). 35 U of Endo-N were added to three dishes maintained in culture at 378C and PSA-NCAM expression was monitored 24, 72 and 120 h after Endo-N addition. The remaining served as control. Experiments were conducted in duplicate for Western blot, and cytometric analysis.
For immuno¯uorescence, cell cultures were seeded on poly-L-lysine coated glass coverslips and ®xed with 4% paraformaldehyde. For double labeling, cells were incubated with anti-NCAM and anti-PSA antibodies for 1 h at room temperature. Bound antibodies were revealed with¯uor-escein-conjugated goat anti-rabbit IgG (Jackson, Immunotech, Marseille, France; 1/50 dilution) and rhodamineconjugated goat anti-mouse IgM (Immunotech; 1/50 dilution). Controls included nonspeci®c mouse IgM, rabbit IgG, or secondary antibodies alone; none showed staining. The cells were examined under a Zeiss¯uorescence microscope with appropriate ®lters.
For Western blot analysis the cells were harvested and lysed by addition of 50 ml of lysis buer (Nonidet P40 2%, Tris 40 mM, EDTA 20 mM, PMSF 1/1000, H 2 O). After centrifugation (14 000 g for 5 min), samples were boiled for 3 min in reducing electrophoresis buer. Controls included human embryonic and adult brain extracts. Membrane extracts were prepared as previously described (FigarellaBranger et al., 1990) . Aliquots containing an equivalent amount of proteins were resolved on 7% SDS ± PAGE. Proteins were transferred onto nitrocellulose sheets (Amersham, Les Ulys, France) for 4 h at 60 V and then processed for NCAM and PSA-NCAM detection (Figarella-Branger et al., 1990) .
For cytometric analysis, 10 6 cells were washed in PBS-EDTA 20 mM buer and incubated 60 min with primary antibodies (anti-PSA-NCAM 1/200 and anti-NCAM 1/1000). No ®xation was done prior to staining and non speci®c binding was blocked by a 15 min incubation with 10% FBS. Cells were then incubated for 1 h with FITC-conjugated goat anti-mouse IgM (Jackson, Immunotech, Marseille, France) and phycoerythrin-conjugated goat anti-rabbit IgG (Caltag Laboratories, TEBU, Le Perray-en-Yvelines, France). More than 10 4 cells were recorded and analysed by FACScan¯ow cytometry (Becton-Dickinson, San JoseÂ , CA, USA).
Proliferation assay
TE 671 cells were cultured in 32-well plates (wells of 2.5 cm 2 and 5610 4 cells/well). Endo-N was added to the medium in 16 wells (35 U per well); the other half served as controls. The number of cells per well was monitored every 24 h for 5 days. Four wells with Endo-N and four control wells were counted for each assay. Only viable cells were counted (Trypan-blue exclusion).
Mice and animal irradiation
Six-week-old outbred nu/nu female mice were used for tumor implantation. The mice were purchased from CERJ (CentreElevage-Robert-Janvier, Rennes, France). They were maintained in a sterile environment and received sterile food and water ad libitum. No drugs were added to drinking water. The nude mice were pretreated with 400 rad whole-body irradiation, using a 137 Cs source 4 days before cell injection to depress primary natural killer activity. Note that few mice (5%) died from bone marrow aplasia after irradiation. The whole-body irradiation produces a depletion of NK cells and NK activity; recovery occurs within 10 weeks (Silobrcic et al., 1990) . This treatment was essential for the experiments conducted here because of the high content of NK cells in the peritoneal sera (Rapoport et al., 1999) .
Cell injection and tumor monitoring
TE 671 cells were resuspended in DMEM before injection. Aliquots (100 ml) containing 10 6 viable cells were inoculated in irradiated mice using a 1 ml syringe. Injections were performed s.c. (in the¯anks, six mice), i.v. (in a lateral tail vein, six mice), i.p. (six mice), and i.m. (seven mice). The tumors were measured twice a week. The i.m. inoculated tumors were measured by the increase in thigh circumference. For the s.c. tumors, the tumor volume (V) was calculated according to the formula: V=p/66L6W6T (L: length; W: width; T: thickness). For the i.p. inoculated mice, ascites were evaluated by the increase in abdominal circumference. The mice were killed by cervical spinal cord rupture and autopsied 8 weeks after inoculation. For the i.m. injected animals autopsy was performed 6 weeks after injection because of the rapid growth of primary tumors.
Lungs, brains, kidneys, spleens, livers, and primary tumors were ®xed in 4% buered formaldehyde for 24 h and embedded in paran. Some specimens (primary tumors and lungs) were also frozen in liquid nitrogen for immunohistochemistry. For conventional histology, the blocks of each organ and tumor were cut into 5-mm-thick paran sections. One out of ®ve sections were stained by Hematoxylin-Eosin. For immunohistochemistry, serial 5-mm-thick sections were obtained. One section was treated with anti-PSA antibody and the others were used as controls (omission of primary antibody and irrelevant IgM). Immunoperoxidase staining was performed using avidin peroxidase complex (ABC Kits, Vector, Burlingame, USA) as previously described (FigarellaBranger et al., 1992) .
Endo-N injection and tumor monitoring
Toxicity of Endo-N was evaluated by intraperitoneal injection of 350 Units (U) in ®ve healthy animals. The mice were killed and autopsied 2 weeks after inoculation. Organs were treated as above.
Endo-N pretreated TE 671 cells ( 10 6 ) were injected in 29 mice (i.p.: 15 and i.m.: 14). Some mice (i.p.: 9 and i.m.: 8) were injected i.p. twice a week with Endo-N in DMEM (35 U in a total volume of 250 ml), others (six mice in each group) received a control injection of 250 ml DMEM twice a week. The mice were killed as described above. In six injected and three control mice, ascites were collected and stored at 7808C; PSA levels were measured by using an ELISA previously described (Dubois et al., 1995) . Primary tumors, lungs, and livers were processed as above. The amount (35 U) and the frequency (twice a week) of Endo-N administered in each mouse was decided after the results of in vitro analyses.
Statistical analysis
The number of metastases and the PSA-NCAM levels in ascites were compared in the Endo-N group and control mice. The nonparametric Fisher's exact test and Mann ± Whitney U-test were used respectively (BMDP system 1.1/PC software).
